It’s happening here in Florida! More than 400 scientists, entrepreneurs, investors and biotech industry experts are expected to gather in Fort Lauderdale this month for the annual BioFlorida conference.
“It is designed “to showcase the business and scientific achievements in the industry and encourage collaborations and partnerships,” said Nancy Bryan, CEO and president of the West Palm Beach-based BioFlorida. Those in the industry have much to celebrate, as Florida’s biotech industry grew in companies and incubators by nearly 15 percent in 2017, one of the strongest results since 2008, according to BioFlorida.”
“On January 4, CDRH issued its first draft device guidance of the year. The Draft Guidance “Unique Device Identification: Convenience Kits” explains FDA’s position as to what constitutes a convenience kit for purposes of the UDI Rule.”
“HDMA’s 2014-15 Factbook updates member financial, operational performance.
The just-published 2014-15 Factbook, a compilation of HDMA member data as well as relevant industry statistics, gives evidence that full-line wholesalers are running faster—shipping more products each day, while handling a higher daily average of orders. The report also provides a snapshot of what the industry was looking like in 2013 just as the Drug Supply Chain Security Act was passed; presumably, the report from a year from now will show how ready the industry was for the Jan. 1, 2015, deadline coming up for reporting transaction information to customers and FDA, per DSCSA requirements. ”
Wholesale drug distributors are a link between manufacturers and health care professionals. Their role is to ensure prescription medications are delivered safely and efficiently to thousands of health care practitioners and pharmacies nationwide every day.
While the U.S. health care supply chain is one of the most secure and sophisticated in the world, there is a growing network of rogue wholesale drug distributors selling potentially unsafe drugs in the U.S. market.”